Literature DB >> 19223467

DNA ligase I deficiency leads to replication-dependent DNA damage and impacts cell morphology without blocking cell cycle progression.

Samuela Soza1, Valentina Leva, Riccardo Vago, Giovanni Ferrari, Giuliano Mazzini, Giuseppe Biamonti, Alessandra Montecucco.   

Abstract

46BR.1G1 cells derive from a patient with a genetic syndrome characterized by drastically reduced replicative DNA ligase I (LigI) activity and delayed joining of Okazaki fragments. Here we show that the replication defect in 46BR.1G1 cells results in the accumulation of both single-stranded and double-stranded DNA breaks. This is accompanied by phosphorylation of the H2AX histone variant and the formation of gammaH2AX foci that mark damaged DNA. Single-cell analysis demonstrates that the number of gammaH2AX foci in LigI-defective cells fluctuates during the cell cycle: they form in S phase, persist in mitosis, and eventually diminish in G(1) phase. Notably, replication-dependent DNA damage in 46BR.1G1 cells only moderately delays cell cycle progression and does not activate the S-phase-specific ATR/Chk1 checkpoint pathway that also monitors the execution of mitosis. In contrast, the ATM/Chk2 pathway is activated. The phenotype of 46BR.1G1 cells is efficiently corrected by the wild-type LigI but is worsened by a LigI mutant that mimics the hyperphosphorylated enzyme in M phase. Notably, the expression of the phosphomimetic mutant drastically affects cell morphology and the organization of the cytoskeleton, unveiling an unexpected link between endogenous DNA damage and the structural organization of the cell.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223467      PMCID: PMC2663296          DOI: 10.1128/MCB.01730-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  27 in total

1.  Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.

Authors:  Raffaella Di Micco; Marzia Fumagalli; Angelo Cicalese; Sara Piccinin; Patrizia Gasparini; Chiara Luise; Catherine Schurra; Massimiliano Garre'; Paolo Giovanni Nuciforo; Aaron Bensimon; Roberta Maestro; Pier Giuseppe Pelicci; Fabrizio d'Adda di Fagagna
Journal:  Nature       Date:  2006-11-30       Impact factor: 49.962

2.  The dispersal of replication proteins after Etoposide treatment requires the cooperation of Nbs1 with the ataxia telangiectasia Rad3-related/Chk1 pathway.

Authors:  Rossella Rossi; Maria Rosa Lidonnici; Samuela Soza; Giuseppe Biamonti; Alessandra Montecucco
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

Review 3.  DNA damage checkpoints: from initiation to recovery or adaptation.

Authors:  Jiri Bartek; Jiri Lukas
Journal:  Curr Opin Cell Biol       Date:  2007-02-15       Impact factor: 8.382

4.  ATM-dependent DNA damage-independent mitotic phosphorylation of H2AX in normally growing mammalian cells.

Authors:  Kirk J McManus; Michael J Hendzel
Journal:  Mol Biol Cell       Date:  2005-07-19       Impact factor: 4.138

Review 5.  Cellular response to etoposide treatment.

Authors:  Alessandra Montecucco; Giuseppe Biamonti
Journal:  Cancer Lett       Date:  2006-12-12       Impact factor: 8.679

6.  Adaptation to the ionizing radiation-induced G2 checkpoint occurs in human cells and depends on checkpoint kinase 1 and Polo-like kinase 1 kinases.

Authors:  Randi G Syljuåsen; Sanne Jensen; Jiri Bartek; Jiri Lukas
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

7.  The Mre11 complex mediates the S-phase checkpoint through an interaction with replication protein A.

Authors:  Erin Olson; Christian J Nievera; Enbo Liu; Alan Yueh-Luen Lee; Longchuan Chen; Xiaohua Wu
Journal:  Mol Cell Biol       Date:  2007-06-25       Impact factor: 4.272

8.  ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.

Authors:  Shuhei Matsuoka; Bryan A Ballif; Agata Smogorzewska; E Robert McDonald; Kristen E Hurov; Ji Luo; Corey E Bakalarski; Zhenming Zhao; Nicole Solimini; Yaniv Lerenthal; Yosef Shiloh; Steven P Gygi; Stephen J Elledge
Journal:  Science       Date:  2007-05-25       Impact factor: 47.728

Review 9.  Interplay of replication checkpoints and repair proteins at stalled replication forks.

Authors:  Dana Branzei; Marco Foiani
Journal:  DNA Repair (Amst)       Date:  2007-03-26

10.  RETRACTED: Sealing of chromosomal DNA nicks during nucleotide excision repair requires XRCC1 and DNA ligase III alpha in a cell-cycle-specific manner.

Authors:  Jill Moser; Hanneke Kool; Ioannis Giakzidis; Keith Caldecott; Leon H F Mullenders; Maria I Fousteri
Journal:  Mol Cell       Date:  2007-07-20       Impact factor: 17.970

View more
  21 in total

1.  8-Oxoguanine DNA glycosylase-1-mediated DNA repair is associated with Rho GTPase activation and α-smooth muscle actin polymerization.

Authors:  Jixian Luo; Koa Hosoki; Attila Bacsi; Zsolt Radak; Muralidhar L Hegde; Sanjiv Sur; Tapas K Hazra; Allan R Brasier; Xueqing Ba; Istvan Boldogh
Journal:  Free Radic Biol Med       Date:  2014-03-26       Impact factor: 7.376

Review 2.  Altered DNA ligase activity in human disease.

Authors:  Alan E Tomkinson; Tasmin Naila; Seema Khattri Bhandari
Journal:  Mutagenesis       Date:  2020-02-13       Impact factor: 3.000

3.  Genetic determinants for promoter hypermethylation in the lungs of smokers: a candidate gene-based study.

Authors:  Shuguang Leng; Christine A Stidley; Yushi Liu; Christopher K Edlund; Randall P Willink; Younghun Han; Maria Teresa Landi; Michael Thun; Maria A Picchi; Shannon E Bruse; Richard E Crowell; David Van Den Berg; Neil E Caporaso; Christopher I Amos; Jill M Siegfried; Yohannes Tesfaigzi; Frank D Gilliland; Steven A Belinsky
Journal:  Cancer Res       Date:  2011-12-02       Impact factor: 12.701

4.  Methylation of FEN1 suppresses nearby phosphorylation and facilitates PCNA binding.

Authors:  Zhigang Guo; Li Zheng; Hong Xu; Huifang Dai; Mian Zhou; Mary Rose Pascua; Qin M Chen; Binghui Shen
Journal:  Nat Chem Biol       Date:  2010-08-22       Impact factor: 15.040

5.  CTG/CAG repeat instability is modulated by the levels of human DNA ligase I and its interaction with proliferating cell nuclear antigen: a distinction between replication and slipped-DNA repair.

Authors:  Arturo López Castel; Alan E Tomkinson; Christopher E Pearson
Journal:  J Biol Chem       Date:  2009-07-22       Impact factor: 5.157

Review 6.  DNA ligase I, the replicative DNA ligase.

Authors:  Timothy R L Howes; Alan E Tomkinson
Journal:  Subcell Biochem       Date:  2012

7.  Phosphorylation of human DNA ligase I regulates its interaction with replication factor C and its participation in DNA replication and DNA repair.

Authors:  Sangeetha Vijayakumar; Barbara Dziegielewska; David S Levin; Wei Song; Jinhu Yin; Austin Yang; Yoshihiro Matsumoto; Vladimir P Bermudez; Jerard Hurwitz; Alan E Tomkinson
Journal:  Mol Cell Biol       Date:  2009-02-17       Impact factor: 4.272

8.  Phosphorylation of serine 51 regulates the interaction of human DNA ligase I with replication factor C and its participation in DNA replication and repair.

Authors:  Zhimin Peng; Zhongping Liao; Barbara Dziegielewska; Yoshi Matsumoto; Stefani Thomas; Yunhu Wan; Austin Yang; Alan E Tomkinson
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

9.  Okazaki fragment processing-independent role for human Dna2 enzyme during DNA replication.

Authors:  Julien P Duxin; Hayley R Moore; Julia Sidorova; Kenneth Karanja; Yuchi Honaker; Benjamin Dao; Helen Piwnica-Worms; Judith L Campbell; Raymond J Monnat; Sheila A Stewart
Journal:  J Biol Chem       Date:  2012-05-07       Impact factor: 5.157

10.  Biallelic mutations in DNA ligase 1 underlie a spectrum of immune deficiencies.

Authors:  Patrick Maffucci; Jose Chavez; Thomas J Jurkiw; Patrick J O'Brien; Jordan K Abbott; Paul R Reynolds; Austen Worth; Luigi D Notarangelo; Kerstin Felgentreff; Patricia Cortes; Bertrand Boisson; Lin Radigan; Aurélie Cobat; Chitra Dinakar; Mohammad Ehlayel; Tawfeg Ben-Omran; Erwin W Gelfand; Jean-Laurent Casanova; Charlotte Cunningham-Rundles
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.